Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBlue Cross Blue Shield NC leadless pacemaker Cover…
    Ask Trek AI about this page
    ModifiedBlue Cross Blue Shield - North CarolinaPolicy N/A

    Leadless Cardiac Pacemakers

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - North Carolina policy alerts

    Know when Blue Cross Blue Shield - North Carolina releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical policy governing coverage and clinical criteria for leadless (transcatheter) cardiac pacemakers for Blue Cross Blue Shield of North Carolina members; affects providers requesting coverage and prior authorization for these devices and related procedures.

    Policy Summary
    PayerBlue Cross Blue Shield - North Carolina
    PolicyLeadless Cardiac Pacemakers
    Policy CodePolicy N/A
    Change TypeScope and coding updates (2024–2025)
    Effective DateApr 1, 2026
    Last ReviewDec 29, 2023
    Next Review DateApr 1, 2026
    Key ActionSubmit medical records and documentation when requested to support determination of medical necessity for leadless pacemaker coverage.
    SourceLink
    POLICY UPDATE CHANGES

    Updates to When Covered and Not Covered sections in 7/30/25 changed language to refer to 'Single chamber (right ventricular)' and removed brand-specific references such as 'The Micra' and 'The Aveir™'.

    Code C1605 was added to the Billing/Coding section effective 7/1/24.

    Added numerous temporary CPT/T code additions (0795T–0804T, 0823T–0826T) to the Billing/Coding section across 2023–2024 updates.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ~200,000approximate annual pacemaker implants in the United States
    >99%reported procedural success in pivotal Micra study
    3.5–4%Micra pivotal study major complication incidence
    6.7%Aveir 1-year major complications
    T-codes + C1605policy lists procedure codes
    2015–2025referenced sources range

    Coverage Criteria for Leadless Cardiac Pacemakers

    Eligibility for covered single‑chamber leadless pacemaker

    Covered when ALL of the following are met:

    ALL of the following

    • ALL of the following

      • ONE of

        • Symptomatic paroxysmal or permanent high-grade atrioventricular (AV) block
        • Symptomatic bradycardia–tachycardia syndrome
        • Sinus node dysfunction (sinus bradycardia or sinus pauses)
    • ALL of the following

      • ONE of

        • History of an endovascular or cardiovascular implantable electronic device (CIED) infection or high risk for infection
        • Limited transvenous access for pacing (e.g., venous anomaly, occlusion of axillary veins, planned use of those veins for a semi-permanent catheter, or current/planned use of an arteriovenous fistula for hemodialysis)
        • Presence of a bioprosthetic tricuspid valve

    Coverage criteria and notes

    Policy-level coverage statements, evidence considerations, and operational notes:

    ALL of the following

    • ALL of the following

      • Evidence for dual‑chamber leadless pacing is insufficient to determine improvement in net health outcome; a pivotal prospective single‑cohort study reported a 12‑month complication‑free rate of 88.6% (95% CI: 84.5%–91.8%) and met the composite atrial capture performance endpoint in 92.8% of individuals; acute and long‑term events are being captured in a post‑approval study through 9 years.
    • ALL of the following

      • No evidence exclusively enrolling individuals medically ineligible for conventional pacing was identified; evidence is insufficient to determine net health outcome improvement in this subgroup.
    • ALL of the following

      • Other alternatives (epicardial leads, transiliac placement) have limited data: epicardial leads are associated with longer ICU stay, greater blood loss, and longer ventilation times versus conventional systems; transiliac placement case series report atrial lead dislodgement rates of approximately 7%–21%.

    Billing, CPT/HCPCS and Service Codes

    Applicable service codesmixed
    0795T
    0796T
    0797T
    0798T
    0799T
    0800T
    0801T
    0802T
    0803T
    0804T
    1–10 of 15
    1/2
    Applicable service codesCPT | HCPCS | mixed
    0795T
    0796T
    0797T
    0798T
    0799T
    0800T
    0801T
    0802T
    0803T
    0804T
    1–10 of 15
    1/2
    Applicable service codes — additional/updates (2023–2024)mixed
    0795TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    0796TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    0797TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    0798TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    0799TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    0800TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    0801TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    0802TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    0803TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    0804TTemporary/procedure codes listed as applicable service codes (added 6/30/23 effective 7/1/23).
    1–10 of 15
    1/2

    Prior Authorization, Documentation, and Billing Notes

    Prior Authorization

    Prior authorization and documentation may be requested; codes do not guarantee reimbursement

    BCBSNC may request medical records and other documentation to determine medical necessity; letters of support or explanation alone are not sufficient unless they include all information needed for the determination. Inclusion of a code in the policy’s billing/coding section does not guarantee it will be reimbursed.

    • BCBSNC may request medical records for determination of medical necessity; letters of support/explanation are not sufficient unless all specific information is provided.
    • Inclusion of a code in the Billing/Coding section does not guarantee reimbursement.
    Billing Rule

    Billing/coding codes listed; be prepared to provide full medical records

    Definitions and Terminology

    Conventional pacemaker — key facts
    DefinitionTransvenous pacemaker with pulse generator and leads; generator implanted in chest (pre-pectoral or subpectoral) transmits impulses via electrodes affixed to the myocardium.
    ComponentsPulse generator (battery and electronics) and one or more transvenous leads (single- or dual-chamber configurations).
    Clinical noteSingle-chamber systems typically place one lead in the right ventricle; dual-chamber systems use atrial and ventricular leads.
    Leadless pacemaker — key facts
    DefinitionSelf-contained, hermetically sealed capsule that houses battery and electronics and is implanted via femoral venous access without transvenous leads.
    DeliveryIntroduced via a large-bore femoral venous sheath using a steerable delivery catheter (eg, Micra delivered using a 23 French catheter).
    Policy Summary
    PayerBlue Cross Blue Shield - North Carolina
    PolicyLeadless Cardiac Pacemakers
    Policy CodePolicy N/A
    Change TypeScope and coding updates (2024–2025)
    Effective DateApr 1, 2026
    Last ReviewDec 29, 2023
    Next Review DateApr 1, 2026
    Key ActionSubmit medical records and documentation when requested to support determination of medical necessity for leadless pacemaker coverage.
    SourceLink
    On This Page
    Coverage Criteria for Leadless Cardiac PacemakersBilling, CPT/HCPCS and Service CodesPrior Authorization, Documentation, and Billing NotesDefinitions and Terminology
  1. ALL of the following

    • Policy language was updated (7/1/24 and 7/30/25) to clarify scope: statements were changed to refer to 'Single chamber (right ventricular)' devices and brand‑specific references were removed; the Aveir DR (dual‑chamber) and right atrial single‑chamber transcatheter systems are designated investigational for all indications per the updates.
  2. ALL of the following

    • Inclusion of procedure codes in the policy does not guarantee reimbursement; BCBSNC may request medical records and documentation to determine medical necessity.
  3. Applicable service codes are listed in the policy, but inclusion does not ensure reimbursement. BCBSNC may request medical records to determine medical necessity when these codes are billed.

    • Applicable service codes: 0795T, 0796T, 0797T, 0798T, 0799T, 0800T, 0801T, 0802T, 0803T, 0804T, 0823T, 0824T, 0825T, 0826T, C1605.
    • When medical records are requested, provide complete documentation; letters of support/explanation are not sufficient unless they include all required information for medical necessity determination.
    ExamplesClinically evaluated devices include Micra and Aveir single‑chamber transcatheter pacing systems.
    Rate‑modulated pacing — key facts
    DefinitionPacing that adjusts heart rate in response to physiologic signals (rate‑responsive) to support patients with chronotropic incompetence.
    IndicationIndicated for patients with chronotropic incompetence or who benefit from increased stimulation rates with activity.
    Device capabilityLeadless devices commonly include rate‑responsive functionality (eg, accelerometer‑based rate response).
    Epicardial leads — key facts
    DefinitionPacing leads placed on the epicardial (surface) of the heart, typically used when thoracotomy is already planned.
    Clinical/resource tradeoffsAssociated with longer intensive care unit stays, greater blood loss, and longer ventilation times compared with conventional transvenous systems.
    Use caseMost relevant for patients undergoing thoracotomy for underlying conditions (eg, congenital heart disease).
    Transiliac placement — key facts
    DefinitionAn alternative transvenous access route for pacemaker leads via the iliac/retrograde approach (transiliac placement) with limited supporting evidence.
    Reported complicationsSmall case series report atrial lead dislodgement rates ranging from 7% to 21%.
    Evidence qualityEvidence is limited to small case series; overall data are insufficient to determine improved net health outcomes using this approach.